Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Molecular therapy for Osteoporosis: The stem cell protein Oct-4 suppresses the expression of a bone formation inhibitor Sclerostin via down regulation of its target gene, 6/September/2014, 05.43 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at email@example.com
* Research cooperation
Significance: This study suggests, for the first time, that Oct-4 may promote bone mass and formation. Thus, pharmacological formulations encompassing “Oct-4 activator” may be used to treat Osteoporosis.